D-Wave Quantum announced plans to collaborate on a joint proof-of-concept project that will leverage quantum computing technology and artificial intelligence in the drug discovery process, i.e., “Quantum AI-driven Drug Discovery.”…”In our development of AI-driven drug discovery systems, we have been focusing on and researching quantum computing technologies as a speed and quality accelerator in the drug design process,” said Dr. Masaru Tateno, Chief Scientific Officer CSO of JT’s Pharmaceutical Research Center…Following the proof-of-concept project, JT’s pharmaceutical division plans to further advance the developed, Quantum AI-driven Drug Discovery analysis systems and eventually move the application of quantum computing technology into production operations.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QBTS:
- D-Wave Quantum Appoints New Chief Human Resources Officer
- D-Wave Quantum appoints Sophie Ames as chief human resources officer
- D-Wave Quantum Partners with Staque for Middle East Expansion
- D-Wave Quantum, Staque announce new strategic partnership
- D-Wave Quantum Hosts Groundbreaking UAE Quantum Event